Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

To determine long-term safety and efficacy of pregabalin in patients with partial seizures.

Official Title

Pregabalin Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.

Conditions

Seizure Disorder, Partial

Study Type

Interventional

Study Design

Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study

Further Details

Study Start

March 2002; Study completion: November 2005

Eligibility & Criteria

• Ages Eligible for Study: 18 Years and above
• Genders Eligible for Study: Both

Inclusion Criteria:

• Must have met the inclusion criteria for preceding double-blind study
• Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion Criteria:

• Cannot be pregnant or considering becoming pregnant during the course of the study.
• Cannot be receiving any concomitant medication that could alter the effectiveness of the pregabalin response or affect seizure frequency.

Total Enrolment

337

Contact Details

Locations:

• Deakin, Australian Capital Territory, 2600, Australia
• Chastwood, New South Wales, 2067, Australia
• Camperdown, New South Wales, 2050, Australia
• Maroochydore, Queensland, 4558, Australia
• Cairns, Queensland, 4870, Australia
• Footscray, Victoria, 3011, Australia
• Parkville, Victoria, 3050, Australia
• Perth, Western Australia, 6001, Australia

For more information on this study, click here.